LIRRX | OAYIX | LIRRX / OAYIX | |
Total Expense Ratio | 1.24 | 0.88 | 141% |
Annual Report Gross Expense Ratio | 1.24 | 0.88 | 141% |
Fund Existence | 17 years | 9 years | - |
Gain YTD | 19.886 | 21.852 | 91% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 100000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 446M | 14.4B | 3% |
Annual Yield % from dividends | 2.60 | 2.21 | 118% |
Returns for 1 year | 15.37 | 15.90 | 97% |
Returns for 3 years | 52.81 | 43.64 | 121% |
Returns for 5 years | 62.89 | 61.68 | 102% |
Returns for 10 years | 46.09 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBP | 62.66 | 0.45 | +0.72% |
Virtus LifeSci Biotech Products ETF | |||
XFLT | 5.57 | 0.02 | +0.36% |
XAI Octagon Floating Rate and Alternative Income Trust | |||
FENI | 33.04 | 0.06 | +0.18% |
Fidelity Enhanced International ETF | |||
KF | 27.33 | 0.04 | +0.16% |
Korea Fund | |||
EVLU | 28.06 | -0.11 | -0.37% |
iShares MSCI Emerging Mkts Val Fac ETF |